within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01B_Antimetabolites.L01BB02_Mercaptopurine;

model Mercaptopurine
  extends Pharmacolibrary.Drugs.ATC.L.L01BB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01BB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mercaptopurine is an antimetabolite and purine analog used primarily in the treatment of acute lymphoblastic leukemia and other hematologic malignancies. It works by inhibiting DNA and RNA synthesis in rapidly dividing cells. Mercaptopurine is still approved and commonly used as part of chemotherapy regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with acute lymphoblastic leukemia under oral administration.</p><h4>References</h4><ol><li><p>Larsen, RH, et al., &amp; Nersting, J (2020). Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. <i>Cancer chemotherapy and pharmacology</i> 86(1) 25–32. DOI:<a href=\"https://doi.org/10.1007/s00280-020-04097-x\">10.1007/s00280-020-04097-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32519032/\">https://pubmed.ncbi.nlm.nih.gov/32519032</a></p></li><li><p>Toksvang, LN, et al., &amp; Schmiegelow, K (2022). Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. <i>Leukemia</i> 36(7) 1749–1758. DOI:<a href=\"https://doi.org/10.1038/s41375-022-01591-4\">10.1038/s41375-022-01591-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35654820/\">https://pubmed.ncbi.nlm.nih.gov/35654820</a></p></li><li><p>Balis, FM, et al., &amp; Bleyer, WA (1998). Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children&#x27;s cancer group and pediatric oncology branch study. <i>Blood</i> 92(10) 3569–3577. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9808549/\">https://pubmed.ncbi.nlm.nih.gov/9808549</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Mercaptopurine;
